Lowest-Rated StocksLowest-RatedNYSE:FMS Fresenius Medical Care AG & Co. KGaA (FMS) Stock Price, News & Analysis $22.20 +0.10 (+0.43%) Closing price 03:59 PM EasternExtended Trading$22.20 +0.01 (+0.05%) As of 07:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Fresenius Medical Care AG & Co. KGaA Stock (NYSE:FMS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get FMS alerts:Sign Up Key Stats Today's Range$21.89▼$22.2650-Day Range$20.16▼$23.7052-Week Range$20.02▼$30.46Volume710,461 shsAverage Volume665,898 shsMarket Capitalization$12.40 billionP/E Ratio11.68Dividend Yield2.75%Price Target$28.00Consensus RatingReduce Company Overview Fresenius Medical Care AG & Co. KGaA is the world’s largest integrated provider of products and services for individuals with renal diseases. The company’s primary business activities encompass the operation of dialysis clinics and the manufacture and distribution of dialysis equipment, dialysis machines, dialyzers, consumables and related therapies. Through its global network of clinics, Fresenius Medical Care delivers comprehensive kidney care, including hemodialysis and peritoneal dialysis treatments, patient education and support services. In its products segment, the company designs and produces dialysis machines, water treatment systems and disposables such as high‐flux dialyzers and bloodlines. These offerings are complemented by a range of pharmaceuticals, including anticoagulants and iron therapies, along with digital health solutions for remote patient monitoring and data management. By integrating clinical expertise with proprietary technology, Fresenius Medical Care aims to improve treatment outcomes and enhance patient quality of life. Founded in 1996 as a spin‐off from the Fresenius SE healthcare group, Fresenius Medical Care is headquartered in Bad Homburg, Germany. The company maintains a presence in over 50 countries across North America, Europe, Latin America and the Asia Pacific region. Its global reach is supported by manufacturing facilities, research centers and a network of more than 4,000 dialysis clinics, serving hundreds of thousands of patients worldwide.AI Generated. May Contain Errors. Read More Fresenius Medical Care AG & Co. KGaA Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks91st Percentile Overall ScoreFMS MarketRank™: Fresenius Medical Care AG & Co. KGaA scored higher than 91% of companies evaluated by MarketBeat, and ranked 13th out of 851 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.6 / 5Analyst RatingReduce Consensus RatingFresenius Medical Care AG & Co. KGaA has received a consensus rating of Reduce. The company's average rating score is 1.56, and is based on no strong buy ratings, no buy ratings, 5 hold ratings, and 4 sell ratings.Upside PotentialFresenius Medical Care AG & Co. KGaA has a consensus price target of $28.00, representing about 26.2% upside from its current price of $22.20.Amount of Analyst CoverageFresenius Medical Care AG & Co. KGaA has only been the subject of 4 research reports in the past 90 days.Read more about Fresenius Medical Care AG & Co. KGaA's stock forecast and price target. Earnings and Valuation3.1 / 5Proj. Earnings Growth8.48% Earnings GrowthEarnings for Fresenius Medical Care AG & Co. KGaA are expected to grow by 8.48% in the coming year, from $2.24 to $2.43 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Fresenius Medical Care AG & Co. KGaA is 11.68, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.53.Price to Earnings Ratio vs. SectorThe P/E ratio of Fresenius Medical Care AG & Co. KGaA is 11.68, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 20.74.Price to Earnings Growth RatioFresenius Medical Care AG & Co. KGaA has a PEG Ratio of 4.01. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioFresenius Medical Care AG & Co. KGaA has a P/B Ratio of 0.75. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Fresenius Medical Care AG & Co. KGaA's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.26% of the float of Fresenius Medical Care AG & Co. KGaA has been sold short.Short Interest Ratio / Days to CoverFresenius Medical Care AG & Co. KGaA has a short interest ratio ("days to cover") of 2.64, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Fresenius Medical Care AG & Co. KGaA has recently decreased by 8.78%, indicating that investor sentiment is improving significantly. Dividend2.5 / 5Dividend StrengthModerate Dividend YieldFresenius Medical Care AG & Co. KGaA pays a meaningful dividend of 2.64%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthFresenius Medical Care AG & Co. KGaA does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Fresenius Medical Care AG & Co. KGaA is 32.11%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Fresenius Medical Care AG & Co. KGaA will have a dividend payout ratio of 25.10% next year. This indicates that Fresenius Medical Care AG & Co. KGaA will be able to sustain or increase its dividend.Read more about Fresenius Medical Care AG & Co. KGaA's dividend. News and Social Media1.3 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for Fresenius Medical Care AG & Co. KGaA this week, compared to 1 article on an average week.Search Interest6 people have searched for FMS on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.MarketBeat Follows2 people have added Fresenius Medical Care AG & Co. KGaA to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership0.1 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Fresenius Medical Care AG & Co. KGaA insiders have not sold or bought any company stock.Percentage Held by Institutions8.37% of the stock of Fresenius Medical Care AG & Co. KGaA is held by institutions.Read more about Fresenius Medical Care AG & Co. KGaA's insider trading history. Receive FMS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Fresenius Medical Care AG & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. FMS Stock News HeadlinesFresenius Medical Care Reappoints Chief Financial Officer Martin FischerMay 20 at 1:00 PM | prnewswire.comFresenius Medical Care AG & Co. KGaA (0H9X) Gets a Sell from Morgan StanleyMay 8, 2026 | theglobeandmail.comA 17-year investing experiment investigated in DublinPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.May 20 at 1:00 AM | Porter & Company (Ad)Goldman Sachs Remains a Hold on Fresenius Medical Care AG & Co. KGaA (0H9X)May 8, 2026 | theglobeandmail.comFresenius Medical Care AG & Co. KGaA (0H9X) Gets a Hold from Deutsche BankMay 8, 2026 | theglobeandmail.comFresenius Medical: The Undervaluation Is Getting ClearerMay 5, 2026 | seekingalpha.comFresenius Medical Care AG 2026 Q1 - Results - Earnings Call PresentationMay 5, 2026 | seekingalpha.comFresenius Medical Care delivers strong operating income growth in Q1 2026 while advancing the U.S. rollout of 5008X CAREsystems at speedMay 5, 2026 | prnewswire.comSee More Headlines FMS Stock Analysis - Frequently Asked Questions How have FMS shares performed this year? Fresenius Medical Care AG & Co. KGaA's stock was trading at $23.84 at the beginning of 2026. Since then, FMS shares have decreased by 6.9% and is now trading at $22.1950. How were Fresenius Medical Care AG & Co. KGaA's earnings last quarter? Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) released its earnings results on Tuesday, March, 31st. The company reported $1.05 earnings per share for the quarter. The firm had revenue of $5.34 billion for the quarter. Fresenius Medical Care AG & Co. KGaA had a trailing twelve-month return on equity of 8.90% and a net margin of 4.88%. Does Fresenius Medical Care AG & Co. KGaA have any subsidiaries? The following companies are subsidiaries of Fresenius Medical Care AG & Co. KGaA: NxStage Medical. Who are Fresenius Medical Care AG & Co. KGaA's major shareholders? Fresenius Medical Care AG & Co. KGaA's top institutional investors include Pzena Investment Management LLC (2.69%), Moran Wealth Management LLC (0.06%), Quantinno Capital Management LP (0.06%) and Royal Bank of Canada (0.04%). How do I buy shares of Fresenius Medical Care AG & Co. KGaA? Shares of FMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Fresenius Medical Care AG & Co. KGaA own? Based on aggregate information from My MarketBeat watchlists, some other companies that Fresenius Medical Care AG & Co. KGaA investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Energy Transfer (ET), AbbVie (ABBV), GE Aerospace (GE) and Adobe (ADBE). Company Calendar Last Earnings3/31/2026Today5/20/2026AGM 20265/21/2026Record date for 6/8 Dividend5/22/2026Ex-Dividend for 6/8 Dividend5/22/2026Dividend Payable6/08/2026Next Earnings (Estimated)8/04/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (6m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 FMS's financial health is in the Red zone, according to TradeSmith. FMS has been in this zone for over 6 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry MED INSTRUMENTS Sub-IndustryHealthcare Current SymbolNYSE:FMS CIK1333141 Webwww.freseniusmedicalcare.com Phone(496) 172-6090Fax49-6172-609-2301Employees1,488Year Founded1912Price Target and Rating Average Price Target for Fresenius Medical Care AG & Co. KGaA$28.00 High Price Target$28.00 Low Price Target$28.00 Potential Upside/Downside+26.2%Consensus RatingReduce Rating Score (0-4)1.56 Research Coverage9 Analysts Profitability EPS (Trailing Twelve Months)$1.90 Trailing P/E Ratio11.68 Forward P/E Ratio9.91 P/E Growth4.01Net Income$1.11 billion Net Margins4.88% Pretax Margin7.53% Return on Equity8.90% Return on Assets4.05% Debt Debt-to-Equity Ratio0.40 Current Ratio1.20 Quick Ratio0.86 Sales & Book Value Annual Sales$19.36 billion Price / Sales0.64 Cash Flow$5.56 per share Price / Cash Flow3.99 Book Value$29.76 per share Price / Book0.75Miscellaneous Outstanding Shares558,578,000Free FloatN/AMarket Cap$12.40 billion OptionableOptionable Beta0.81 Social Links The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (NYSE:FMS) was last updated on 5/20/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredAre we ignoring the same signal Wall Street ignored in 1929?In 1929, Irving Weiss spotted a systemic crisis hiding beneath record highs and shorted the market - turning $...Weiss Ratings | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredTrump Is Eyeing the Biggest Monetary Shift Since NixonOn August 15, 1971, Nixon ended the Bretton Woods agreement and untethered the dollar from gold. Since that ni...Americas Gold Company | SponsoredOne page of the SpaceX S-1 will move this stock overnightWhen SpaceX files its S-1 in June, the SEC will require full disclosure of operating expenses - including powe...Behind the Markets | SponsoredThe Death of the Nasdaq?The Death of the Nasdaq? Wall Street legend Marc Chaikin's award-winning system turned bearish on software ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fresenius Medical Care AG & Co. KGaA Please log in to your account or sign up in order to add this asset to your watchlist. Share Fresenius Medical Care AG & Co. KGaA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
